Effect of Osteopathic Technique on Maximum Mouth Opening Width, Masseter Muscle Tone and Stiffness

June 22, 2026 updated by: Natália Maria Oliveira Campelo, Escola Superior de Tecnologia da Saúde do Porto

Effect of Temporomandibular Joint Compression and Decompression Technique on Maximum Mouth Opening Width, Masseter Muscle Tone and Stiffness: A Randomized Controlled Study

The purpose of this study is to assess the effect of compression and decompression thecnique on the temporomandibular joint on maximum mouth opening width, masseter muscle tone and stiffness in asymptomatic adults, compared with a control condition consisting of cranial listening touch without therapeutic intent. Evaluations will be conducted immediately after the intervention and one week later.

Study Overview

Status

Not yet recruiting

Detailed Description

The purpose of this study is to assess the Effect of Compression and Decompression Technique on the Temporomandibular Joint (Liem et al, 2012) on masseter muscle tone and stiffness (always assessed on the right side). Muscle properties will be evaluated using the Myoton device (Myoton AS, Tallinn, Estonia), a non-invasive instrument that measures biomechanical and viscoelastic properties of muscles, such as stiffness and tone (the parameters used in the results).

In addition, maximum mouth-opening width will be assessed by measuring the distance between the upper and lower central incisors using a universal caliper (Oliveira-Campelo et al., 2010), recorded in millimeters.

These outcomes will be compared with a control condition consisting of cranial listening touch without therapeutic intent .

The study will include asymptomatic adults without diagnoses of systemic inflammatory diseases, cardiovascular diseases, respiratory diseases , central nervous system disorders, or rheumatic pathologies. Additional exclusion criteria include: use of fixed orthodontic appliances within the past 3 months; visual impairment affecting balance or proprioception; history of maxillofacial surgery; trauma to the cranial or cervical region within the last 6 months ; ongoing pharmacological treatments that may interfere with muscle tone or pain perception (e.g., muscle relaxants, tricyclic antidepressants, benzodiazepines) and third/fourth year osteopathy students.

Measurements of the tone/stiffness of the masseter muscle and maximum mouth opening width will conducted before, immediately after the intervention and one week later the study will be repeated in each participant.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Natália MO Campelo, PhD
  • Phone Number: +351 222 061 000
  • Email: nmc@ess.ipp.pt

Study Locations

      • Porto, Portugal, 4200-072
        • Escola Superior de Saúde (E2S)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Asymptomatic adults that signed the informed consent
  • Functional dentition
  • Preserved masticatory function

Exclusion Criteria:

  • Diagnosis of inflammatory systemic disorders
  • Diagnosis of cardiovascular disorders
  • Diagnosis of respiratory disorders
  • Diagnosis of central nervous system disorders
  • Diagnosis of rheumatic disorders
  • Visual disturbance affecting balance or proprioception

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control group
In the control group, cranial listening touch without therapeutic intent using the par la voute hold was performed during 30 seconds.

Cranial listening touch without therapeutic intent consists of, with the patient in the supine position and the investigator at the head of the bed, the investigator placing bilateral contacts on the patient's skull with the first fingers in contact with each other, without contacting the skull, the second fingers on the greater wing of the sphenoid, the third fingers anterior to the ear, the fourth fingers posterior to the ear, and the fifth fingers in contact with the squamous part of the occipital bone (Busquet, 2002).

In addition, after placing the contacts, the investigator asks the patient not to contact the maxillary teeth with the mandibular teeth.

Experimental: Temporomandibular Compression and Decompression Technique
The intervention consisted of two phases: The first one consisting in mandibular compression, applied for 30 seconds. The second phase is applied right after, consisting in mandibular decompression, applied for 30 seconds.
The temporomandibular joint compression and decompression technique consists of, with the patient in the supine position and the investigator at the head, hooking the middle fingers beneath the angles of the mandible while the basal joints cover the joints and the palms cover the ears and temporal regions (Liem et al, 2012). First, a light cranially-directed pressure is applied to the mandible for 30 seconds to release restrictions and stretch the intracranial membrane. Subsequently, the vector is reversed, and a gentle caudally-directed traction is applied for another 30 seconds to free the joint space."

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum Mouth Opening Width
Time Frame: Immediately after the intervention. Since the protocol has two interventions, the total time frame is one week.
For the assessment of the maximum mouth opening width was measured the distance between the upper and lower central incisors was measured in millimeters (mm) using a universal caliper.
Immediately after the intervention. Since the protocol has two interventions, the total time frame is one week.
Masseter Muscle Tone
Time Frame: Immediately after the intervention. Since the protocol has two interventions, the total time frame is one week.
The assessment of masseter muscle tone was performed using Myoton (Myoton AS Talin, Estonia), a non-invasive approach to comprehensively evaluate the biomechanical and viscoelastic properties of muscles. Muscle tone is calculated using the maximum frequency of oscillation and tissue deformation detected by the transducer (Hz).
Immediately after the intervention. Since the protocol has two interventions, the total time frame is one week.
Masseter muscle stiffness
Time Frame: Immediately after the intervention. Since the protocol has two interventions, the total time frame is one week.
The assessment of masseter muscle stiffness was performed using Myoton (Myoton AS Talin, Estonia), a non-invasive approach to comprehensively evaluate the biomechanical and viscoelastic properties of muscles. Muscle stiffness is calculated based on equations calculated from the acceleration of the testing probe during oscillations (N/m).
Immediately after the intervention. Since the protocol has two interventions, the total time frame is one week.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Natália MO Campelo, E2S

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

June 22, 2026

First Posted (Actual)

June 26, 2026

Study Record Updates

Last Update Posted (Actual)

June 26, 2026

Last Update Submitted That Met QC Criteria

June 22, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asymptomatic Condition

Clinical Trials on Placebo Technique

Subscribe